(VIANEWS) - Continental Resources (CLR), Sociedad Quimica y Minera S.A. (SQM), Eagle Point Credit Company (ECC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Continental Resources (CLR)
61.6% sales growth and 5.52% return on equity
Continental Resources, Inc. explores for, develops, and produces crude oil and natural gas properties primarily in the north, south, and east regions of the United States.
Continental Resources's sales growth this year is anticipated to be 99.1% and a negative 3% for next year.
Year-on-year quarterly revenue growth grew by 597.9%, now sitting on 3.8B for the twelve trailing months.
Volume
Today's last reported volume for Continental Resources is 1309550 which is 22.47% below its average volume of 1689120.
Continental Resources's sales growth is a negative 0% for the current quarter and 61.6% for the next. The company's growth estimates for the present quarter and the next is 812.5% and 595.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.52%.
Volatility
Continental Resources's last day, last week, and last month's current volatility was 2.62%, 2.21%, and 2.44%, respectively.
Continental Resources's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.98% (day), 3.65% (last week), and 3.98% (last month), respectively.
Continental Resources's Stock Yearly Top and Bottom Value
Continental Resources's stock is valued at $47.36 at 16:22 EST, below its 52-week high of $47.80 and way higher than its 52-week low of $11.61.
Continental Resources's Moving Average
Continental Resources's worth is way higher than its 50-day moving average of $39.87 and way higher than its 200-day moving average of $33.87.2. Sociedad Quimica y Minera S.A. (SQM)
37.5% sales growth and 8.67% return on equity
Sociedad QuÃmica y Minera de Chile S.A. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services.
Sociedad Quimica y Minera S.A.'s sales growth this year is anticipated to be 29.2% and 24.3% for next year.
Year-on-year quarterly revenue growth grew by 28.3%, now sitting on 2.08B for the twelve trailing months.
Volume
Today's last reported volume for Sociedad Quimica y Minera S.A. is 722831 which is 41.68% below its average volume of 1239550.
Sociedad Quimica y Minera S.A.'s sales growth is a negative 0% for the present quarter and 37.5% for the next. The company's growth estimates for the current quarter and the next is 88.2% and 4100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.67%.
Volatility
Sociedad Quimica y Minera S.A.'s last day, last week, and last month's current volatility was 1.40%, 1.78%, and 1.89%, respectively.
Sociedad Quimica y Minera S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.75% (day), 2.31% (last week), and 3.25% (last month), respectively.
Sociedad Quimica y Minera S.A.'s Stock Yearly Top and Bottom Value
Sociedad Quimica y Minera S.A.'s stock is valued at $52.89 at 16:22 EST, way below its 52-week high of $60.74 and way above its 52-week low of $30.77.
Sociedad Quimica y Minera S.A.'s Moving Average
Sociedad Quimica y Minera S.A.'s value is below its 50-day moving average of $53.02 and higher than its 200-day moving average of $50.41.3. Eagle Point Credit Company (ECC)
35.2% sales growth and 63.5% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC.
Eagle Point Credit Company's sales growth this year is expected to be 28.2% and 14.8% for next year.
Year-on-year quarterly revenue growth grew by 29.6%, now sitting on 67.64M for the twelve trailing months.
Volume
Today's last reported volume for Eagle Point Credit Company is 274984 which is 65.57% above its average volume of 166082.
Eagle Point Credit Company's sales growth for the next quarter is 35.2%. The company's growth estimates for the current quarter and the next is 342.9% and 17.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.5%.
Volatility
Eagle Point Credit Company's last day, last week, and last month's current volatility was 0.59%, 1.14%, and 0.67%, respectively.
Eagle Point Credit Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.32% (day), 1.46% (last week), and 1.36% (last month), respectively.
Eagle Point Credit Company's Stock Yearly Top and Bottom Value
Eagle Point Credit Company's stock is valued at $13.70 at 16:22 EST, under its 52-week high of $14.44 and way higher than its 52-week low of $7.44.
Eagle Point Credit Company's Moving Average
Eagle Point Credit Company's value is below its 50-day moving average of $13.80 and higher than its 200-day moving average of $13.23.4. The Shyft Group (SHYF)
33.3% sales growth and 27.76% return on equity
The Shyft Group, Inc., through its subsidiary Spartan Motors USA, Inc., manufactures and assembles specialty vehicles for the commercial vehicle and recreational vehicle industries in the United States and internationally.
The Shyft Group's sales growth this year is expected to be 36.1% and 11.4% for next year.
Year-on-year quarterly revenue growth grew by 96.8%, now sitting on 816.92M for the twelve trailing months.
Volume
Today's last reported volume for The Shyft Group is 179029 which is 14.85% above its average volume of 155876.
The Shyft Group's sales growth for the next quarter is 33.3%. The company's growth estimates for the ongoing quarter and the next is a negative 12.9% and 74.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.76%.
Volatility
The Shyft Group's last day, last week, and last month's current volatility was 4.31%, 5.33%, and 2.25%, respectively.
The Shyft Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.39% (day), 3.81% (last week), and 2.89% (last month), respectively.
The Shyft Group's Stock Yearly Top and Bottom Value
The Shyft Group's stock is valued at $39.65 at 16:22 EST, way below its 52-week high of $45.08 and way higher than its 52-week low of $18.74.
The Shyft Group's Moving Average
The Shyft Group's value is below its 50-day moving average of $41.67 and above its 200-day moving average of $38.99.5. West Pharmaceutical (WST)
21.2% sales growth and 28.54% return on equity
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.
West Pharmaceutical's sales growth this year is anticipated to be 30.4% and 8% for next year.
Year-on-year quarterly revenue growth grew by 37.3%, now sitting on 2.52B for the twelve trailing months.
Volume
Today's last reported volume for West Pharmaceutical is 508568 which is 54.03% above its average volume of 330160.
West Pharmaceutical's sales growth for the next quarter is 21.2%. The company's growth estimates for the ongoing quarter and the next is 56.5% and 41.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.54%.
Volatility
West Pharmaceutical's last day, last week, and last month's current volatility was 1.15%, 2.67%, and 1.09%, respectively.
West Pharmaceutical's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.46% (day), 2.88% (last week), and 1.83% (last month), respectively.
West Pharmaceutical's Stock Yearly Top and Bottom Value
West Pharmaceutical's stock is valued at $419.73 at 16:22 EST, way below its 52-week high of $475.35 and way above its 52-week low of $253.86.
West Pharmaceutical's Moving Average
West Pharmaceutical's value is below its 50-day moving average of $448.46 and way above its 200-day moving average of $367.84.6. Mobile TeleSystems OJSC (MBT)
10% sales growth and 112.02% return on equity
Mobile TeleSystems Public Joint Stock Company provides telecommunication services primarily in Russia.
Mobile TeleSystems OJSC's sales growth this year is expected to be 7.3% and 4.2% for next year.
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 501.39B for the twelve trailing months.
Volume
Today's last reported volume for Mobile TeleSystems OJSC is 2459050 which is 1.04% below its average volume of 2485060.
Mobile TeleSystems OJSC's sales growth for the next quarter is 10%. The company's growth estimates for the current quarter and the next is 133.3% and 6.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 112.02%.
Volatility
Mobile TeleSystems OJSC's last day, last week, and last month's current volatility was 1.65%, 1.01%, and 1.19%, respectively.
Mobile TeleSystems OJSC's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.38% (day), 2.58% (last week), and 1.97% (last month), respectively.
Mobile TeleSystems OJSC's Stock Yearly Top and Bottom Value
Mobile TeleSystems OJSC's stock is valued at $9.86 at 16:22 EST, below its 52-week high of $10.07 and way above its 52-week low of $7.72.
Mobile TeleSystems OJSC's Moving Average
Mobile TeleSystems OJSC's worth is higher than its 50-day moving average of $9.18 and way higher than its 200-day moving average of $8.87.7. CrossFirst Bankshares (CFB)
5.6% sales growth and 7.02% return on equity
CrossFirst Bankshares's sales growth this year is expected to be 8.6% and 2.4% for next year.
Year-on-year quarterly revenue growth grew by 87.1%, now sitting on 146.53M for the twelve trailing months.
Volume
Today's last reported volume for CrossFirst Bankshares is 83855 which is 7.25% above its average volume of 78184.
CrossFirst Bankshares's sales growth for the next quarter is 5.6%. The company's growth estimates for the current quarter and the next is 100% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.02%.
Volatility
CrossFirst Bankshares's last day, last week, and last month's current volatility was 1.64%, 1.93%, and 1.67%, respectively.
CrossFirst Bankshares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.02% (day), 2.63% (last week), and 3.02% (last month), respectively.
CrossFirst Bankshares's Stock Yearly Top and Bottom Value
CrossFirst Bankshares's stock is valued at $13.43 at 16:22 EST, way below its 52-week high of $15.67 and way higher than its 52-week low of $8.25.